AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Schmitz, FJ Petridou, J Fluit, AC Hadding, U Peters, G von Eiff, C
Citation: Fj. Schmitz et al., Distribution of macrolide-resistance genes in Staphylococcus aureus blood-culture isolates from fifteen German university hospitals, EUR J CL M, 19(5), 2000, pp. 385-387

Authors: Bongaerts, RJM Heinz, HP Hadding, U Zysk, G
Citation: Rjm. Bongaerts et al., Antigenicity, expression, and molecular characterization of surface-located pullulanase of Streptococcus pneumoniae, INFEC IMMUN, 68(12), 2000, pp. 7141-7143

Authors: Fischer, HG Dorfler, R Schade, B Hadding, U
Citation: Hg. Fischer et al., Differential CD86/B7-2 expression and cytokine secretion induced by Toxoplasma gondii in macrophages from resistant or susceptible BALB H-2 congenic mice, INT IMMUNOL, 11(3), 1999, pp. 341-349

Authors: Daubener, W Posdziech, V Hadding, U MacKenzie, CR
Citation: W. Daubener et al., Inducible anti-parasitic effector mechanisms in human uroepithelial cells:tryptophan degradation vs. NO production, MED MICROBI, 187(3), 1999, pp. 143-147

Authors: Kitzerow, A Hadding, U Henrich, B
Citation: A. Kitzerow et al., Cyto-adherence studies of the adhesin P50 of Mycoplasma hominis, J MED MICRO, 48(5), 1999, pp. 485-493

Authors: Henrich, B Hopfe, M Kitzerow, A Hadding, U
Citation: B. Henrich et al., The adherence-associated lipoprotein P100, encoded by an opp operon structure, functions as the oligopeptide-binding domain OppA of a putative oligopeptide transport system in Mycoplasma hominis, J BACT, 181(16), 1999, pp. 4873-4878

Authors: Daubener, W Hucke, C Seidel, K Hadding, U MacKenzie, CR
Citation: W. Daubener et al., Interleukin-1 inhibits gamma interferon-induced bacteriostasis in human uroepithelial cells, INFEC IMMUN, 67(11), 1999, pp. 5615-5620

Authors: Schmitz, FJ Fluit, AC Luckefahr, M Engler, B Hofmann, B Verhoef, J Heinz, HP Hadding, U Jones, ME
Citation: Fj. Schmitz et al., The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus, J ANTIMICRO, 42(6), 1998, pp. 807-810
Risultati: 1-8 |